Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 289(10): 6978-6990, 2014 Mar 07.
Article in English | MEDLINE | ID: mdl-24451384

ABSTRACT

The universal second messenger cyclic di-GMP (cdG) is involved in the regulation of a diverse range of cellular processes in bacteria. The intracellular concentration of the dinucleotide is determined by the opposing actions of diguanylate cyclases and cdG-specific phosphodiesterases (PDEs). Whereas most PDEs have accessory domains that are involved in the regulation of their activity, the regulatory mechanism of this class of enzymes has remained unclear. Here, we use biophysical and functional analyses to show that the isolated EAL domain of a PDE from Escherichia coli (YahA) is in a fast thermodynamic monomer-dimer equilibrium, and that the domain is active only in its dimeric state. Furthermore, our data indicate thermodynamic coupling between substrate binding and EAL dimerization with the dimerization affinity being increased about 100-fold upon substrate binding. Crystal structures of the YahA-EAL domain determined under various conditions (apo, Mg(2+), cdG·Ca(2+) complex) confirm structural coupling between the dimer interface and the catalytic center. The built-in regulatory properties of the EAL domain probably facilitate its modular, functional combination with the diverse repertoire of accessory domains.


Subject(s)
3',5'-Cyclic-GMP Phosphodiesterases/metabolism , Cyclic GMP/analogs & derivatives , Escherichia coli Proteins/metabolism , Second Messenger Systems , 3',5'-Cyclic-GMP Phosphodiesterases/chemistry , 3',5'-Cyclic-GMP Phosphodiesterases/genetics , Amino Acid Sequence , Catalysis , Catalytic Domain , Crystallography, X-Ray , Cyclic GMP/chemistry , Cyclic GMP/metabolism , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/genetics , Hydrolysis , Molecular Sequence Data , Protein Multimerization , Protein Structure, Tertiary
2.
Heart Lung ; 42(2): 105-11, 2013.
Article in English | MEDLINE | ID: mdl-23110854

ABSTRACT

OBJECTIVES: To examine the temporal contingency of anxiety and implantable cardioverter defibrillator (ICD) therapy (anti-tachycardia-pacing and shocks to prevent ventricular tachycardia and/or fibrillation). BACKGROUND: It is under debate whether anxiety is a precursor and/or consequence of ICD-therapy. METHODS: In a prospective longitudinal study, fifty-four patients undergoing first-time ICD-implantation were assessed for anxiety, frequency of ICD-shocks and anti-tachycardia-pacing up to two days before ICD-implantation (T0) and twelve months later (T1). RESULTS: Anxiety at T0 did not predict frequency of ICD-shocks at T1, but ICD-shocks significantly predicted increased anxiety at T1. In contrast, anxiety at T0 and T1 was unrelated to frequency of anti-tachycardia-pacing. Effects remained stable when we controlled for potentially confounding variables (e.g. age, sex, cardiac health and depression at T0). CONCLUSION: Our findings indicate that repeated ICD-shocks are a cause of anxiety in ICD-patients rather than a consequence, thus shock frequency should be minimized.


Subject(s)
Anxiety/diagnosis , Arrhythmias, Cardiac , Depression/diagnosis , Electric Countershock , Adult , Aged , Anxiety/epidemiology , Anxiety/etiology , Anxiety/physiopathology , Arrhythmias, Cardiac/epidemiology , Arrhythmias, Cardiac/psychology , Arrhythmias, Cardiac/therapy , Confounding Factors, Epidemiologic , Defibrillators, Implantable , Depression/etiology , Depression/physiopathology , Electric Countershock/adverse effects , Electric Countershock/instrumentation , Electric Countershock/methods , Episode of Care , Female , Germany/epidemiology , Humans , Male , Middle Aged , Outcome and Process Assessment, Health Care , Prospective Studies , Psychiatric Status Rating Scales , Psychopathology , Risk Factors , Time Factors
3.
Appl Biochem Biotechnol ; 163(1): 71-9, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20582742

ABSTRACT

Cyclic di-GMP (c-di-GMP) is an almost universal bacterial second messenger involved in the regulation of cell surface-associated traits and the persistence of infections. GGDEF and EAL domain-containing proteins catalyse c-di-GMP synthesis and degradation, respectively. We report the enzymatic large-scale synthesis of c-di-GMP, making use of the GGDEF domain-containing protein YdeH from Escherichia coli. Overexpression and purification of YdeH have been established, and the conditions for c-di-GMP synthesis were optimised. In contrast to the chemical synthesis of c-di-GMP, enzymatic c-di-GMP production is a one-step reaction that can easily be performed with the equipment of a standard biochemical lab. The protocol allows the production of milligram amounts of c-di-GMP within 1 day and paves the way for extensive biochemical and biophysical studies on c-di-GMP-mediated processes.


Subject(s)
Cyclic GMP/biosynthesis , Escherichia coli Proteins/metabolism , Escherichia coli/enzymology , Phosphorus-Oxygen Lyases/metabolism , Second Messenger Systems , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/genetics , Escherichia coli Proteins/isolation & purification , Gene Expression Regulation, Bacterial , Phosphorus-Oxygen Lyases/chemistry , Phosphorus-Oxygen Lyases/genetics , Phosphorus-Oxygen Lyases/isolation & purification , Protein Structure, Tertiary
4.
Chemistry ; 16(43): 12883-9, 2010 Nov 15.
Article in English | MEDLINE | ID: mdl-20878805

ABSTRACT

The mode of action of precious metal anticancer metallodrugs is generally believed to involve DNA as a target. However, the poor specificity of such drugs often requires high doses and leads to undesirable side-effects. With the aim of improving the specificity of a ruthenium piano-stool complex towards DNA, we employed a presenter protein strategy based on the biotin-avidin technology. Guided by the X-ray structure of the assembly of streptavidin and a biotinylated piano-stool, we explored the formation of metallodrug-mediated ternary complexes with the presenter protein and DNA. The assemblies bound more strongly to telomere G-quadruplexes than to double-stranded DNA; chemo-genetic modifications (varying the complex or mutating the protein) modulated binding to these targets. We suggest that rational targeting of small molecules by presenter proteins could be exploited to bind metallodrugs to preferred macromolecular targets.


Subject(s)
DNA/chemistry , Organometallic Compounds/chemistry , Proteins/chemistry , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , DNA/drug effects , DNA/metabolism , Drug Design , G-Quadruplexes/drug effects , Molecular Structure , Organometallic Compounds/chemical synthesis , Protein Binding , Proteins/metabolism , Ruthenium/chemistry , Streptavidin/chemistry
5.
Biochimie ; 92(10): 1445-53, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20637827

ABSTRACT

We have recently investigated and characterized the mode of action of BcPeh28A, an endopolygalacturonase (endoPG) from the phytopathogen Burkholderia cepacia. EndoPGs belong to glycoside hydrolase family 28 and are responsible for the hydrolysis of the non-esterified regions of pectins. Here we report a 3-D structural model of BcPeh28A by combining mass spectrometry (MS) analysis, aimed at disulphide bridges mapping, and computational modelling tools. MS analyses have revealed the complete pattern of disulphide bridges in BcPeh28A, pointing out the presence of three disulphide bonds, defined as Cys3-25, Cys216-244 and Cys309-421. A 3-D model of BcPeh28A was generated by computational methods based on profile-profile sequence alignments and fold recognition algorithms. The final model exhibits a right-handed ß-helix fold with eleven ß-helical coils and includes the disulphide bonds as additional spatial restraints. Molecular dynamics simulations have been performed to test the conformational stability of the model. Finally, the structural analysis of the BcPeh28A model allows defining the architecture and the amino acid topology of the subsites involved in the catalysis and in the substrate binding specificity.


Subject(s)
Burkholderia cepacia/enzymology , Polygalacturonase/chemistry , Bacterial Proteins/chemistry , Catalytic Domain , Computational Biology/methods , Disulfides , Enzyme Stability , Mass Spectrometry , Models, Molecular , Molecular Dynamics Simulation , Protein Conformation , Substrate Specificity
6.
J Biol Chem ; 284(19): 13174-84, 2009 May 08.
Article in English | MEDLINE | ID: mdl-19244251

ABSTRACT

Cyclic di-GMP (c-di-GMP) is a ubiquitous bacterial second messenger that is involved in the regulation of cell surface-associated traits and the persistence of infections. Omnipresent GGDEF and EAL domains, which occur in various combinations with regulatory domains, catalyze c-di-GMP synthesis and degradation, respectively. The crystal structure of full-length YkuI from Bacillus subtilis, composed of an EAL domain and a C-terminal PAS-like domain, has been determined in its native form and in complex with c-di-GMP and Ca(2+). The EAL domain exhibits a triose-phosphate isomerase-barrel fold with one antiparallel beta-strand. The complex with c-di-GMP-Ca(2+) defines the active site of the putative phosphodiesterase located at the C-terminal end of the beta-barrel. The EAL motif is part of the active site with Glu-33 of the motif being involved in cation coordination. The structure of the complex allows the proposal of a phosphodiesterase mechanism, in which the divalent cation and the general base Glu-209 activate a catalytic water molecule for nucleophilic in-line attack on the phosphorus. The C-terminal domain closely resembles the PAS-fold. Its pocket-like structure could accommodate a yet unknown ligand. YkuI forms a tight dimer via EAL-EAL and trans EAL-PAS-like domain association. The possible regulatory significance of the EAL-EAL interface and a mechanism for signal transduction between sensory and catalytic domains of c-di-GMP-specific phosphodiesterases are discussed.


Subject(s)
Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Cyclic GMP/analogs & derivatives , Organophosphates/metabolism , Amino Acid Sequence , Bacillus subtilis/genetics , Bacillus subtilis/metabolism , Bacterial Proteins/genetics , Binding Sites , Catalysis , Crystallization , Crystallography, X-Ray , Cyclic GMP/chemistry , Cyclic GMP/metabolism , Molecular Sequence Data , Organophosphates/chemistry , Protein Binding , Protein Structure, Tertiary , Second Messenger Systems , Selenomethionine , Sequence Homology, Amino Acid
7.
Biochem J ; 407(2): 207-17, 2007 Oct 15.
Article in English | MEDLINE | ID: mdl-17627609

ABSTRACT

We have recently isolated and heterologously expressed BcPeh28A, an endopolygalacturonase from the phytopathogenic Gram-negative bacterium Burkholderia cepacia. Endopolygalacturonases belong to glycoside hydrolase family 28 and are responsible for the hydrolysis of the non-esterified regions of pectins. The mode of action of BcPeh28A on different substrates has been investigated and its enzymatic mechanism elucidated. The hydrolysis of polygalacturonate indicates that BcPeh28A is a non-processive enzyme that releases oligomers with chain lengths ranging from two to eight. By inspection of product progression curves, a kinetic model has been generated and extensively tested. It has been used to derive the kinetic parameters that describe the time course of the formation of six predominant products. Moreover, an investigation of the enzymatic activity on shorter substrates that differ in their overall length and methylation patterns sheds light on the architecture of the BcPeh28A active site. Specifically the tolerance of individual sites towards methylated saccharide units was rationalized on the basis of the hydrolysis of hexagalacturonides with different methylation patterns.


Subject(s)
Burkholderia cepacia/enzymology , Polygalacturonase/metabolism , Bacterial Proteins , Binding Sites , Hexuronic Acids , Hydrolysis , Kinetics , Methylation , Pectins/metabolism , Substrate Specificity
8.
Protein Expr Purif ; 54(2): 300-8, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17493828

ABSTRACT

Endo-polygalacturonases (endoPGs) belong to the glycoside hydrolase family 28 and hydrolyze the alpha-1,4 glycosidic bond present in the smooth regions of pectins. Pectic substances are among the principal macromolecular components of the primary plant cell walls and are subjected to enzymatic degradation not only in the course of important physiological processes such as plant senescence and ripening, but also during infection events by plant pathogens. Here we report, for the first time, the isolation and the purification of an endoPG (PehA) from the supernatant of the plant pathogen Burkholderia cepacia strain ATCC 25416. In order to obtain adequate amounts of protein required for structural and functional studies, the gene coding for pehA was PCR-amplified and cloned in Escherichia coli cells. The recombinant protein was purified to homogeneity and characterized. PehA exhibited a pI value of 8.0 and an optimal activity at pH 3.5. Far-UV circular dichroism (CD) measurements show that PehA assumes a beta-helix fold super-secondary structural motif.


Subject(s)
Burkholderia cepacia/enzymology , Polygalacturonase/isolation & purification , Amino Acid Sequence , Electrophoresis, Polyacrylamide Gel , Enzyme Stability , Escherichia coli/metabolism , Molecular Sequence Data , Polygalacturonase/chemistry , Polygalacturonase/metabolism , Recombinant Proteins/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...